We are live on
!
Find out more
Royal London Asset Management Portfolio holdings
AUM
$54.3B
1-Year Est. Return
39.21%
This Fund
S&P 500
This Quarter
Est. Return
-2.06%
1 Year Est. Return
+39.21%
3 Year Est. Return
+125.97%
5 Year Est. Return
+167.16%
10 Year Est. Return
–
AUM
$30.9B
AUM Growth
-$37.6M
(-0.12%)
Cap. Flow
+$884M
Cap. Flow
% of AUM
2.86%
Top 10 Holdings %
Top 10 Hldgs %
31.36%
Holding
699
New
20
Increased
519
Reduced
68
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mercado Libre
MELI
|
+$129M |
| 2 |
Booking.com
BKNG
|
+$115M |
| 3 |
Kinsale Capital Group
KNSL
|
+$93.4M |
| 4 |
Apple
AAPL
|
+$82.4M |
| 5 |
Tyson Foods
TSN
|
+$67.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$186M |
| 2 |
Visa
V
|
+$128M |
| 3 |
ExxonMobil
XOM
|
+$86.4M |
| 4 |
Philip Morris
PM
|
+$61.6M |
| 5 |
Suncor Energy
SU
|
+$54.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.12% |
| 2 | Healthcare | 15.2% |
| 3 | Financials | 13.37% |
| 4 | Consumer Discretionary | 11.54% |
| 5 | Industrials | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vertex Pharmaceuticals
VRTX
$131B
| $136M | 0.44% |
390,508
+79,001
| +25% | +$27.6M |
|
52
Linde
LIN
$220B
| $126M | 0.41% |
337,079
+158,226
| +88% | +$60.2M |
|
53
Stryker
SYK
$131B
| $119M | 0.38% |
433,810
+162
| +0% | +$46.5K |
|
54
HDFC Bank
HDB
$119B
| $118M | 0.38% |
4,005,152
+1,466,984
| +58% | +$47.8M |
|
55
Merck
MRK
$333B
| $115M | 0.37% |
1,119,964
+55,012
| +5% | +$5.93M |
|
56
Costco
COST
$425B
| $113M | 0.37% |
200,761
+13,883
| +7% | +$7.66M |
|
|
57
Philip Morris
PM
$294B
| $111M | 0.36% |
1,200,456
-640,249
| -35% | -$61.6M |
|
58
IQVIA
IQV
$39.8B
| $105M | 0.34% |
533,207
+15,308
| +3% | +$3.32M |
|
|
59
Kinsale Capital Group
KNSL
$8.57B
| $102M | 0.33% |
245,684
+240,668
| +4,798% | +$93.4M |
|
60
Elevance Health
ELV
$86.4B
| $100M | 0.33% |
230,558
+9,750
| +4% | +$4.42M |
|
61
Coca-Cola
KO
$376B
| $100M | 0.33% |
1,792,350
+112,407
| +7% | +$6.74M |
|
62
S&P Global
SPGI
$124B
| $97.7M | 0.32% |
267,290
+33,145
| +14% | +$13M |
|
|
63
Tyson Foods
TSN
$19.9B
| $96.2M | 0.31% |
1,904,569
+1,261,583
| +196% | +$67.2M |
|
64
TJX Companies
TJX
$169B
| $96.1M | 0.31% |
1,080,781
-41,246
| -4% | -$3.63M |
|
65
Autodesk
ADSK
$54.1B
| $96M | 0.31% |
463,747
+4,534
| +1% | +$953K |
|
66
Walmart Inc
WMT
$918B
| $94.4M | 0.31% |
1,771,323
+101,028
| +6% | +$5.38M |
|
67
Accenture
ACN
$110B
| $94M | 0.3% |
305,860
+28,005
| +10% | +$8.82M |
|
68
Bristol-Myers Squibb
BMY
$132B
| $92.3M | 0.3% |
1,588,968
+161,575
| +11% | +$9.9M |
|
69
Netflix
NFLX
$323B
| $91.6M | 0.3% |
2,426,980
+180,130
| +8% | +$7.64M |
|
70
Church & Dwight Co
CHD
$24B
| $81.9M | 0.27% |
894,001
-8,261
| -0.9% | -$791K |
|
71
McDonald's
MCD
$193B
| $81.9M | 0.27% |
311,025
+6,435
| +2% | +$1.84M |
|
72
Sylvamo
SLVM
$1.55B
| $80.2M | 0.26% |
1,823,426
+690,117
| +61% | +$29.7M |
|
73
Expeditors International
EXPD
$24.2B
| $79.9M | 0.26% |
696,775
+70,254
| +11% | +$8.35M |
|
74
PACCAR
PCAR
$68.6B
| $79.9M | 0.26% |
939,207
-143,787
| -13% | -$12.2M |
|
75
Salesforce
CRM
$164B
| $78.5M | 0.25% |
387,207
+17,333
| +5% | +$3.75M |
|
Similar funds
SCP
Royal London Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Royal London Asset Management held 699 positions worth $30.9B, down 0.12% from $30.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Royal London Asset Management's Q3 2023 filing shows 20 new, 519 increased, 68 reduced and 17 closed positions. Its largest new stake was AGCO: 327,259 shares worth $38.7M. The largest sale was Eli Lilly, an estimated $186M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Royal London Asset Management's largest Q3 2023 buy was AGCO: 327,259 shares worth $38.7M.
- Royal London Asset Management added most to Mercado Libre in Q3 2023, an estimated $129M increase.
- Royal London Asset Management's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $186M.
- Royal London Asset Management fully exited Trex in Q3 2023, selling an estimated $23.6M.
- Royal London Asset Management's ten largest holdings make up 31% of its $30.9B portfolio in Q3 2023.
- Royal London Asset Management opened 20 new positions and closed 17 in Q3 2023.
- Royal London Asset Management's portfolio value fell 0.12% quarter-over-quarter to $30.9B.
Based on Royal London Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.